Edition:
United States

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

67.03USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$67.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
143,996
52-wk High
$74.42
52-wk Low
$25.08

Select another date:

Fri, Nov 10 2017

BRIEF-Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285

* Blueprint Medicines announces new data from ongoing phase 1 clinical trial of BLU-285 in patients with advanced gastrointestinal stromal tumors showing strengthened clinical activity across spectrum of kit and pdgfrα genotypes

BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​

* Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​

BRIEF-Blueprint Medicines Q3 loss per share $0.96

* Blueprint Medicines reports third quarter 2017 financial results

BRIEF-Blueprint Medicines Q2 loss per share $0.86

* Blueprint Medicines reports second quarter 2017 financial results

BRIEF-Blueprint Medicines to evaluate advance disease discovery program opportunities

* Blueprint Medicines to evaluate opportunities to advance rare disease discovery program in fibrodysplasia ossificans progressiva following discontinuation of collaboration with Alexion

BRIEF-Blueprint Medicines announces new phase 1 clinical data for Blu-285

* Blueprint medicines announces new phase 1 clinical data for Blu-285 in advanced gastrointestinal stromal tumors and plans to pursue expedited development in patients with a pdgfrα d842v mutation

Select another date: